Autres langues Harbin Gloria Pharmaceuticals Co., Ltd

Actions

002437

CNE100000QG8

Produits pharmaceutiques

Cours en clôture Shenzhen S.E. 23/09/2026			Varia. 5j.	Varia. 1 janv.
3,640 ^CNY	-3,70%		+7,37%	+18,57%

26/08	HARBIN GLORIA PHARMACEUTICALS Co., LTD publie ses résultats pour le premier semestre clos le 30 juin 2026	CI
27/04	HARBIN GLORIA PHARMACEUTICALS Co., LTD publie ses résultats pour le premier trimestre clos le 31 mars 2026	CI

Autres langues

26/08	HARBIN GLORIA PHARMACEUTICALS Co., LTD Reports Earnings Results for the Half Year Ended June 30, 2026
27/04	HARBIN GLORIA PHARMACEUTICALS Co., LTD Reports Earnings Results for the First Quarter Ended March 31, 2026
14/04	HARBIN GLORIA PHARMACEUTICALS Co., LTD Reports Earnings Results for the Full Year Ended December 31, 2025
15/01	Harbin Gloria Pharmaceuticals Co., Ltd Approves Election of Xu Yuhong as Independent Director, Effective 14 January 2026
28/10/25	HARBIN GLORIA PHARMACEUTICALS Co., LTD Reports Earnings Results for the Nine Months Ended September 30, 2025
26/08/25	HARBIN GLORIA PHARMACEUTICALS Co., LTD Reports Earnings Results for the Half Year Ended June 30, 2025
04/06/25	Harbin Gloria Pharmaceuticals Gets Right to Market Eisai's Mecobalamin Injection
27/05/25	Harbin Gloria Pharmaceuticals Signs Co-Promotion Deal for Lipid Drug
25/04/25	HARBIN GLORIA PHARMACEUTICALS Co., LTD Reports Earnings Results for the First Quarter Ended March 31, 2025
17/03/25	HARBIN GLORIA PHARMACEUTICALS Co., LTD Elects Liu Yueyin as A Non-Independent Director
14/03/25	Tranche Update on HARBIN GLORIA PHARMACEUTICALS Co., LTD's Equity Buyback Plan announced on October 22, 2024.
13/03/25	HARBIN GLORIA PHARMACEUTICALS Co., LTD's Equity Buyback announced on October 22, 2024, has closed with 32,307,224 shares, representing 1.42% for CNY 79.99 million.
10/03/25	Tranche Update on HARBIN GLORIA PHARMACEUTICALS Co., LTD's Equity Buyback Plan announced on October 22, 2024.
07/02/25	HARBIN GLORIA PHARMACEUTICALS Co., LTD Announces Directorate Appointments
07/02/25	Declaration of Voting Results by Harbin Gloria Pharmaceuticals
26/01/25	Harbin Gloria Pharmaceuticals co Provides Information to the Shareholders
26/01/25	Shen Zhenyu Nominates Candidates to the Board of Harbin Gloria Pharmaceuticals
22/11/24	Harbin Gloria Pharmaceuticals Announces Results of the 2024 Third Extraordinary General Meeting
28/10/24	Shen Zhenyu Submits Proposal to Nominate Supervisors at Harbin Gloria Pharmaceuticals
28/10/24	HARBIN GLORIA PHARMACEUTICALS Co., LTD Reports Earnings Results for the Nine Months Ended September 30, 2024
22/10/24	HARBIN GLORIA PHARMACEUTICALS Co., LTD announces an Equity Buyback for CNY 100 million worth of its shares.
21/10/24	HARBIN GLORIA PHARMACEUTICALS Co., LTD authorizes a Buyback Plan.
23/08/24	HARBIN GLORIA PHARMACEUTICALS Co., LTD Reports Earnings Results for the Half Year Ended June 30, 2024
19/08/24	Chinese Securities Watchdog Warns Harbin Gloria Pharma Over Information Inaccuracies
04/07/24	Harbin Gloria Pharmaceuticals' H1 Profit to Soar Up to 360%